Randomized controlled trial of the CGRP receptor antagonist telcagepant for prevention of headache in women with perimenstrual migraine

Aim The aim of this article is to evaluate the safety and efficacy of perimenstrual telcagepant, a CGRP receptor antagonist, for headache prophylaxis. Methods We conducted a randomized, double-blind, placebo-controlled, six-month trial in women with migraine for ≥3 months who experienced perimenstru...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cephalalgia 2016-02, Vol.36 (2), p.148-161
Hauptverfasser:	Ho, Tony W, Ho, Andrew P, Ge, Yang (Joy), Assaid, Christopher, Gottwald, Regina, MacGregor, E Anne, Mannix, Lisa K, van Oosterhout, Willebrordus PJ, Koppenhaver, Janelle, Lines, Christopher, Ferrari, Michel D, Michelson, David
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Alanine Transaminase - blood Azepines - therapeutic use Calcitonin Gene-Related Peptide - antagonists & inhibitors Double-Blind Method Female Humans Imidazoles - therapeutic use Migraine Disorders - etiology Migraine Disorders - prevention & control Premenstrual Syndrome - complications Receptors, Calcitonin Gene-Related Peptide - antagonists & inhibitors
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!